Comparing a blood pressure combination tablet's absorption
Part of Heart & circulation clinical trials.
This trial checks how a new combination blood pressure pill (sacubitril, alisartan, and amlodipine) is absorbed by the body compared to other forms. It is for healthy adults with normal to mildly elevated blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You weigh at least 50 kg, and your body mass index (BMI) is between 19 and 26.
- Your blood pressure is a bit elevated but not high enough for treatment (systolic 110–139, diastolic 65–89).
- You do not smoke more than 5 cigarettes a day and can stop smoking during the trial.
- You are willing to use effective birth control and not donate sperm or eggs for 3 months after the dose.
- You have no serious medical conditions, allergies to blood pressure drugs, or recent surgery or blood donation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses blood and other body measurements to predict how well certain blood pressure medicines will work for you. It may help doctors choose the best treatment sooner, based on your personal “multi-omics” (biomarker) results.
This trial tests a medication (sacubitril/allisartan) for people who have both high blood pressure and are overweight or obese. The goal is to see if it helps lower blood pressure and may also help with weight management.
This study tests a new combination pill that could control high blood pressure better than current medications alone. It is for adults whose blood pressure remains too high despite taking one or two medicines.
This study tests a new combination pill (valsartan plus levamlodipine) to see if it works better than current treatments for people with mild to moderate high blood pressure. It may be an option if your current medication isn't controlling your blood pressure well enough.
This trial tests a new combination blood pressure medicine called CKD-202A. It is for adults with high blood pressure who have not had other treatments or conditions that could affect the results.
This trial tests whether timing blood pressure medications (based on your natural daily body rhythms) can improve blood pressure control. It’s designed for adults with moderately high blood pressure and focuses on who may benefit from a more precise schedule.
Hear when a new Primary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.